|
Video: What is a Stock Split?
|
|
GeoVax Labs is a clinical-stage biotechnology company developing immunotherapies and vaccines against infectious diseases and solid tumor cancers using vector vaccine platforms. Co.'s product pipeline includes human clinical trials in COVID-19 vaccine and a theraphy against head and neck cancer. Additional research and development programs include preventive vaccines against Monkeypox, hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa) and Zika virus, as well as immunotherapies for multiple solid tumors. Co.'s cancer therapy programs are Gedeptin® and MUC1-based Immunotherapy. According to our GOVX split history records, GeoVax Labs has had 1 split. | |
|
GeoVax Labs (GOVX) has 1 split in our GOVX split history database. The split for GOVX took place on January 31, 2024. This was a 1 for 15 reverse split, meaning for each 15 shares of GOVX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 66.6666666666667 share position following the split.
When a company such as GeoVax Labs conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the GOVX split history from start to finish, an original position size of 1000 shares would have turned into 66.6666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into GeoVax Labs shares, starting with a $10,000 purchase of GOVX, presented on a split-history-adjusted basis factoring in the complete GOVX split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
09/25/2020 |
|
End date: |
04/18/2024 |
|
Start price/share: |
$44.10 |
|
End price/share: |
$1.52 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-96.55% |
|
Average Annual Total Return: |
-61.13% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$344.53 |
|
Years: |
3.56 |
|
|
|
Date |
Ratio |
01/31/2024 | 1 for 15 |
|
|